FDA issued a Warning Letter to Amgen, Inc. on 1/27/2014 for a later inspection.
483 Amgen Jun 2001

483 Amgen Jun 2001

Terri Dodds FDA, Jennifer Gogley FDA, Amalia Himaya FDA$595.00 - Available Now

FDA investigators audited the Amgen - Thousand Oaks, CA, United States facility and issued inspectional observations (via FDA 483) on 08 Jun 2001.

Product details

  • Category: Human Drugs
  • Inspection end: 08 Jun 2001
  • Location: Thousand Oaks, United States
  • FEI: 2026154
Add To Cart